Home / Cefotaxime / Italy
IT ATC J01DD01 · updated 2 Nov 2026
Cefotaxime shortage in Italy
Is there a Cefotaxime shortage in Italy?
Yes. As of 2 Nov 2026, 4 Cefotaxime products are reported short in Italy, the first since 24 Aug 2025. The company estimate for the return is 31 Jan 2027. Main reason: commercial decision or withdrawal.
Also short in United States, Germany, Spain, Austria, Czechia, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | BATIXIM | SO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI | 24 Aug 2025 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | CEFOTAXIMA TEVA | TEVA ITALIA S.R.L. | 1 Oct 2026 | 31 Jan 2027 | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | BATIXIM anticipated | SO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI | 28 Dec 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | CEFOTAXIMA TEVA anticipated | TEVA ITALIA S.R.L. | 1 Feb 2027 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.